Biostar Pharmaceuticals Financials
BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Biostar |
Understanding current and past Biostar Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biostar Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Biostar Pharmaceuticals' assets may result in an increase in income on the income statement.
Biostar Pharmaceuticals Stock Summary
Biostar Pharmaceuticals competes with Lifecore Biomedical, Kamada, Shuttle Pharmaceuticals, Cumberland Pharmaceuticals, and Ironwood Pharmaceuticals. Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter and prescription pharmaceutical products for various diseases and conditions in the Peoples Republic of China. The company was incorporated in 2007 and is headquartered in Xianyang, the Peoples Republic of China. Biostar Pharmaceuticals operates under Pharmaceuticals And Biosciences classification in the United States and is traded on OTC Exchange. It employs 200 people.Specialization | Healthcare, Drug Manufacturers - Major |
Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US0906783016 |
CUSIP | 090678202 090678301 090678103 |
Location | China |
Business Address | No 588 Shiji |
Sector | Pharmaceuticals |
Industry | Pharmaceuticals, Biotechnology & Life Sciences |
Benchmark | Dow Jones Industrial |
Website | biostarpharmaceuticals.com |
Phone | 86 29 3368 6638 |
Currency | USD - US Dollar |
Biostar Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Biostar Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Biostar Pharmaceuticals reports annually and quarterly.Return On Equity | 0.0266 | ||||
Return On Asset | 0.0425 | ||||
Target Price | 7.0 | ||||
Number Of Employees | 200 | ||||
Beta | -2923.36 |
Biostar Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biostar Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Biostar Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biostar Pharmaceuticals competition to find correlations between indicators driving Biostar Pharmaceuticals's intrinsic value. More Info.Biostar Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 1.60 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biostar Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Biostar Pharmaceuticals Market Pulse
Quote | 0.01 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.01 |
Low | 0.01 |
High | 0.01 |
Volume | 0 |
Exchange | PINK |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |